| Author (Year) | Trial | ? vs ? | # of Pts | Clinical Indication | Results |
| Saxon (2003) [45] | Single centre reporting experience from multicentre trial | PTFE stent vs PTA (Viabahn) | 28 | Claudicants | Clinical improvement no different. Conclusion different from reported results. Trial closed 1999. |
| Saxon (2008) [101] | RCT as from Saxon (2003) | PTFE stent plus PTA vs PTA (Viabahn) | 100 | Claudicants | Same trial as above restarted. Flawed methodology. |
| Lammer (2013) [67] | RCT long lesions | Viabahn heprin bonded vs BMS | 141 | Claudicants | No difference in 12-month primary patency or incidence of TLR. |
| Reijnen (2017) [102] | RCT multicentre | Heparin bonded endoluminal stent vs FP bypass | 129 | CLI 38% endoluminal and 32% surgical. Both groups 2/3 Rutherford class 2/3 | No difference in outcomes between 2 groups. Results similar to BASil trial, but including claudicants. |